Risk of uncomplicated peptic ulcer in the general population

Study identifier:D5040N00006

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Risk of uncomplicated peptic ulcer in the general population

Medical condition

Peptic Ulcer [Iowa Type (107680.0010)]

Phase

Healthy volunteers

Study drug

Risk of symptomatic peptic ulcer

Sex

All

Actual Enrollment

4000

Study type

Observational

Age

40 Years - 84 Years

Date

Study Start Date: 01 Sept 2012

Primary Completion Date: 01 May 2013

Study Completion Date: 01 May 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2014 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Madrid, Spain

Arms	Assigned Interventions
Cases Patients with symptomatic peptic ulcer (UPU)	Drug: Risk of symptomatic peptic ulcer Current use of drugs (ASA; NSAIDs, SSRI,PPI, H2RA) versus non-use
Control group Control group without symptomatic peptic ulcer (UPU).	Drug: Risk of symptomatic peptic ulcer Current use of drugs (ASA; NSAIDs, SSRI,PPI, H2RA) versus non-use

Documents available

D5040N00006.pdf
Download
D5040N00006_Redacted_Protocol
Download
Trial Results Summaries
Available here

Contacts

Investigators

Principal Investigator

Luis A Garcia Rodriguez

CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )

Risk of uncomplicated peptic ulcer in the general population

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Documents available

D5040N00006.pdf

D5040N00006_Redacted_Protocol

Trial Results Summaries

Contacts

Investigators

Principal Investigator